Interim results of phase 2 trial are promising
Predictive tool should help in treatment decisions
A patient’s mental preparedness counts
Method can eliminate need for liver biopsies in significant number of patients
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Significant reduction in risk for vision loss and disease progression
Brillouin imaging, corneal cross-linking could aid identification and management of keratoconus and postoperative ectasia
Prospective review of parameters improves plan consistency, saves time
Cleveland Clinic conducts comprehensive review of IBD's widespread effects
Results prompt clinical practice change
A quick review of several advances in risk assessment and treatment
Advertisement
Advertisement